Results 11 to 20 of about 456,413 (294)

Recombinant GM-CSF for diseases of GM-CSF insufficiency: Correcting dysfunctional mononuclear phagocyte disorders [PDF]

open access: yesFrontiers in Immunology, 2023
IntroductionEndogenous granulocyte-macrophage colony-stimulating factor (GM-CSF), identified by its ability to support differentiation of hematopoietic cells into several types of myeloid cells, is now known to support maturation and maintain the ...
Hillard M. Lazarus   +15 more
doaj   +4 more sources

GM-CSF-Dependent Inflammatory Pathways [PDF]

open access: yesFrontiers in Immunology, 2019
Pre-clinical models and clinical trials demonstrate that targeting the action of the cytokine, granulocyte macrophage-colony stimulating factor (GM-CSF), can be efficacious in inflammation/autoimmunity reinforcing the importance of understanding how GM ...
John A. Hamilton, John A. Hamilton
doaj   +6 more sources

Surfactant metabolic consequences of overexpression of GM-CSF in the epithelium of GM-CSF-deficient mice [PDF]

open access: yesAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 1997
Granulocyte macrophage colony-stimulating factor (GM-CSF) is a regulator of surfactant metabolism because GM-CSF-deficient mice have abnormally slow clearance and catabolism of saturated phosphatidylcholine (Sat PC) and surfactant protein (SP)-A in airspaces and lung tissue.
M, Ikegami   +3 more
core   +6 more sources

GM-CSF: A Double-Edged Sword in Cancer Immunotherapy

open access: yesFrontiers in Immunology, 2022
Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a cytokine that drives the generation of myeloid cell subsets including neutrophils, monocytes, macrophages, and dendritic cells in response to stress, infections, and cancers.
Srividya Swaminathan   +2 more
exaly   +3 more sources

Chimeric HIV-1 envelope glycoproteins with potent intrinsic granulocyte-macrophage colony-stimulating factor (GM-CSF) activity. [PDF]

open access: yesPLoS ONE, 2013
HIV-1 acquisition can be prevented by broadly neutralizing antibodies (BrNAbs) that target the envelope glycoprotein complex (Env). An ideal vaccine should therefore be able to induce BrNAbs that can provide immunity over a prolonged period of time, but ...
Gözde Isik   +5 more
doaj   +2 more sources

Expression of GM-CSF receptor and “in vitro” effects of GM-CSF on human fibroblasts

open access: yesLife Sciences, 1998
In the present study the effects of Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) on fibroblast growth and activity have been studied. In this regard the AA have evaluated in primary cultures of human gengival normal fibroblasts (PG1 cells): a)-the expression of GM-CSF receptor (GM-CSFR) (alfa unit) on the cell surface; b)-the in vitro ...
Postiglione, L   +6 more
openaire   +5 more sources

GM-CSF promotes pro-inflammatory macrophage activation associated with Akt/mTOR signaling during experimental colitis [PDF]

open access: yesFrontiers in Immunology
BackgroundUlcerative colitis (UC) is an intestinal immune disorder of unknown etiology. Mounting evidence reveals a central role of macrophages in the hemostatic balance of gut immunity, and dysfunctional macrophages are associated with UC pathogenesis ...
Silan Shen   +36 more
doaj   +2 more sources

Targeting GM-CSF in COVID-19 Pneumonia: Rationale and Strategies [PDF]

open access: yesFrontiers in Immunology, 2020
COVID-19 is a clinical syndrome ranging from mild symptoms to severe pneumonia that often leads to respiratory failure, need for mechanical ventilation, and death.
Aldo Bonaventura   +16 more
doaj   +2 more sources

Adverse prognosis of GM-CSF expression in human cutaneous melanoma [PDF]

open access: yesNeoplasia: An International Journal for Oncology Research
Background: GM-CSF, a myeloid-priming cytokine, exhibits context-dependent effects on tumor growth and, despite its clinical use, its role in human melanoma remains undefined.
Elena García-Martínez   +8 more
doaj   +2 more sources

Dense GM-CSFRα-expressing immune infiltration is allied with longer survival of intrahepatic cholangiocarcinoma patients [PDF]

open access: yesPeerJ, 2023
Background Intrahepatic cholangiocarcinoma (iCCA) is a cancer arising from intrahepatic bile duct epithelium. An iCCA incidence is increasing worldwide; however, the outcome of the disease is dismal.
Paksiree Saranaruk   +9 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy